239 related articles for article (PubMed ID: 26036629)
1. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells.
Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Lau YF; Dahiya R; Tanaka Y
Oncotarget; 2015 Jun; 6(18):16341-51. PubMed ID: 26036629
[TBL] [Abstract][Full Text] [Related]
2. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
[TBL] [Abstract][Full Text] [Related]
4. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract][Full Text] [Related]
5. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells.
Fukuhara S; Chang I; Mitsui Y; Chiyomaru T; Yamamura S; Majid S; Saini S; Hirata H; Deng G; Gill A; Wong DK; Shiina H; Nonomura N; Dahiya R; Tanaka Y
Oncotarget; 2014 Nov; 5(22):11297-307. PubMed ID: 25526032
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
[TBL] [Abstract][Full Text] [Related]
7. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
Yeh CC; Lee C; Dahiya R
Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
[TBL] [Abstract][Full Text] [Related]
8. Deficient mismatch repair improves organismal fitness and survival of mice with dysfunctional telomeres.
Siegl-Cachedenier I; Muñoz P; Flores JM; Klatt P; Blasco MA
Genes Dev; 2007 Sep; 21(17):2234-47. PubMed ID: 17785530
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and mutation in the murine small intestine: loss of Mlh1- and Pms2-dependent apoptosis leads to increased mutation in vivo.
Sansom OJ; Bishop SM; Court H; Dudley S; Liskay RM; Clarke AR
DNA Repair (Amst); 2003 Sep; 2(9):1029-39. PubMed ID: 12967659
[TBL] [Abstract][Full Text] [Related]
11. A novel function of protein kinase B as an inducer of the mismatch repair gene hPMS2 degradation.
Jia J; Zhang Y; Cai J; Wang J; Ding H; Zhou J; Fang F; Wang Z
Cell Signal; 2013 Jun; 25(6):1498-504. PubMed ID: 23499907
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic function of human PMS2 compromised by the nonsynonymous single-nucleotide polymorphic variant R20Q.
Marinovic-Terzic I; Yoshioka-Yamashita A; Shimodaira H; Avdievich E; Hunton IC; Kolodner RD; Edelmann W; Wang JY
Proc Natl Acad Sci U S A; 2008 Sep; 105(37):13993-8. PubMed ID: 18768816
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
Wilczak W; Rashed S; Hube-Magg C; Kluth M; Simon R; Büscheck F; Clauditz TS; Grupp K; Minner S; Tsourlakis MC; Möller-Koop C; Graefen M; Adam M; Haese A; Wittmer C; Sauter G; Izbicki JR; Huland H; Schlomm T; Steurer S; Krech T; Lebok P
Carcinogenesis; 2017 Jan; 38(1):19-27. PubMed ID: 27803051
[TBL] [Abstract][Full Text] [Related]
14. An intact Pms2 ATPase domain is not essential for male fertility.
Fischer JM; Dudley S; Miller AJ; Liskay RM
DNA Repair (Amst); 2016 Mar; 39():46-51. PubMed ID: 26753533
[TBL] [Abstract][Full Text] [Related]
15. Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.
Chen PC; Kuraguchi M; Velasquez J; Wang Y; Yang K; Edwards R; Gillen D; Edelmann W; Kucherlapati R; Lipkin SM
PLoS Genet; 2008 Jun; 4(6):e1000092. PubMed ID: 18551179
[TBL] [Abstract][Full Text] [Related]
16. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
17. Expression of mismatch repair gene PMS2 in nasopharyngeal carcinoma and regulation by glycogen synthase kinase-3β in vivo and in vitro.
Fang J; Lei W; Huang X; Li P; Chen X; Zhu X; Wen W; Li H
Auris Nasus Larynx; 2012 Feb; 39(1):71-6. PubMed ID: 21571466
[TBL] [Abstract][Full Text] [Related]
18. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.
Collins SL; Hervé R; Keevil CW; Blaydes JP; Webb JS
PLoS One; 2011; 6(12):e28123. PubMed ID: 22145025
[TBL] [Abstract][Full Text] [Related]
20. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
